(Q46802718)

25 December 2017

title

The association between plasma adiponectin and insulin sensitivity in humans depends on obesity (English)

1 reference

25 December 2017

0 references

9

1 reference

25 December 2017

Hans-Ulrich Häring

8

Hans-Ulrich Häring

1 reference

25 December 2017

7

Michael Stumvoll

1 reference

25 December 2017

2

Andreas Fritsche

1 reference

25 December 2017

Konstantinos Kantartzis

1

Konstantinos Kantartzis

1 reference

25 December 2017

Claus Thamer

4

Claus Thamer

1 reference

25 December 2017

Michael Haap

5

Michael Haap

1 reference

25 December 2017

Otto Tschritter

3

Otto Tschritter

1 reference

25 December 2017

Silke A Herzberg-Schäfer

6

Silke Schäfer

1 reference

25 December 2017

publication date

1 October 2005

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

13

1 reference

25 December 2017

page(s)

1683-1691

1 reference

25 December 2017

issue

10

1 reference

25 December 2017

cites work

You are what you secrete

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin--its role in metabolism and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Discrimination between obesity and insulin resistance in the relationship with adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Molecular mechanisms of insulin resistance and the role of the adipocyte

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.206

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.206

1 reference

25 December 2017

PubMed ID

16286515

1 reference

25 December 2017